GlassScriptPhysician profile
Thomas S Muzzonigro
NPI 1568431765
$1,078.48
in general payments reported to CMS, 2019-2025
7 companies · $571 in 2025
The $571 reported for 2025 was more than what 81% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $8.83 · 2021: $144 · 2022: $166 · 2023: $23.79 · 2024: $164 · 2025: $571.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $759.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $759.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $389.06 | 2021-2025 | Persona |
| Smith+Nephew, INC. | $286.95 | 2025 | Pico, Real Intelligence |
| Stryker Corporation | $211.67 | 2024-2025 | T2, Bio4, Pelvis II |
| Aroa Biosurgery Incorporated | $145.74 | 2025 | |
| Depuy Synthes Sales INC. | $23.79 | 2023 | Lcp, Va-Lcp |
| Cumberland Pharmaceuticals, INC. | $12.44 | 2022 | |
| Heraeus Medical, LLC. | $8.83 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Muzzonigro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.